Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids
- PMID: 22653287
- DOI: 10.1007/s00330-012-2517-z
Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids
Abstract
Objectives: To evaluate the safety and efficacy of US-guided high-intensity focused ultrasound (HIFU) ablation for the treatment of submucosal fibroids
Methods: A total of 76 women with 78 submucosal uterine fibroids (68 type II fibroids, 10 type I fibroids) underwent US-guided HIFU ablation. The pretreatment fibroid diameter ranged from 2.4 to 13.5 cm (mean 5.7 ± 2.3 cm). The fibroids were ablated using a power output of 420-520 W. During follow-up, the volume shrinkage of the ablated fibroids was continuously observed on contrast-enhanced MR and/or contrast-enhanced ultrasound (CEUS). The change of symptoms was evaluated by using the symptom severity score questionnaire.
Results: HIFU ablation was well tolerated in all patients. No major complications occurred. The mean nonperfused ablation ratio was 80 ± 12 % on CEUS. During follow-up, the ablated fibroids shrank significantly over time. The symptoms were alleviated significantly. No patients had amenorrhoea after treatment. Vaginal expulsion of necrotic tissue was seen in 58 % (44/76) of patients after HIFU ablation which disappeared after 2-4 menstrual cycles. Four patients received repeated HIFU ablation for enlarged residual fibroids.
Conclusions: US-guided HIFU ablation may be a safe and effective treatment for submucosal fibroids. Further studies are warranted to observe its influence on fertility.
Key points: • High-intensity focused ultrasound (HIFU) is a new minimally invasive therapeutic technique. • HIFU ablation may be safe and effective for treatment of submucosal fibroids • Treatment is minimally invasive and repeatable. • Vaginal expulsion of necrotic tissue is common after treatment.
Similar articles
-
Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography.Eur J Radiol. 2007 May;62(2):289-94. doi: 10.1016/j.ejrad.2006.11.039. Epub 2007 Jan 26. Eur J Radiol. 2007. PMID: 17258417
-
Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.Eur Radiol. 2020 Mar;30(3):1554-1563. doi: 10.1007/s00330-019-06468-2. Epub 2019 Nov 8. Eur Radiol. 2020. PMID: 31705252 Clinical Trial.
-
[Efficacy and safety of focused ultrasound ablation in treatment of submucosal uterine fibroids].Zhonghua Fu Chan Ke Za Zhi. 2011 Jun;46(6):407-11. Zhonghua Fu Chan Ke Za Zhi. 2011. PMID: 21781578 Chinese.
-
Combination of HIFU with sulfur hexafluoride microbubbles in the treatment of solitary uterine fibroids: a systematic review and meta-analysis.Eur Radiol. 2024 Jun;34(6):3786-3794. doi: 10.1007/s00330-023-10407-7. Epub 2023 Nov 11. Eur Radiol. 2024. PMID: 37950765 Review.
-
Long-term outcome and risk factors of reintervention after high intensity focused ultrasound ablation for uterine fibroids: a systematic review and meta-analysis.Int J Hyperthermia. 2024;41(1):2299479. doi: 10.1080/02656736.2023.2299479. Epub 2024 Jan 2. Int J Hyperthermia. 2024. PMID: 38164630 Review.
Cited by
-
Optimized treatment parameter by computer simulation for high-intensity focused ultrasound treatment of uterine adenomyosis: Short-term and long-term results.PLoS One. 2024 Mar 28;19(3):e0301193. doi: 10.1371/journal.pone.0301193. eCollection 2024. PLoS One. 2024. PMID: 38547090 Free PMC article.
-
Effectiveness of a hysteroscopic tissue removal system device for hysteroscopic myomectomy on patients' quality of life: a randomized clinical trial.BMC Womens Health. 2023 Oct 17;23(1):541. doi: 10.1186/s12905-023-02707-3. BMC Womens Health. 2023. PMID: 37848865 Free PMC article. Clinical Trial.
-
Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids.Sci Rep. 2022 Dec 7;12(1):21155. doi: 10.1038/s41598-022-24994-w. Sci Rep. 2022. PMID: 36476975 Free PMC article.
-
Comparison of Dose and Effectiveness of a Single-Session Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids With Different Sizes.Front Oncol. 2021 Dec 21;11:725193. doi: 10.3389/fonc.2021.725193. eCollection 2021. Front Oncol. 2021. PMID: 34993130 Free PMC article.
-
A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids.Front Surg. 2021 Jun 4;8:663128. doi: 10.3389/fsurg.2021.663128. eCollection 2021. Front Surg. 2021. PMID: 34150838 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources